Business ❯ Corporate Governance ❯ Investor Relations

Public Companies

Securities Fraud Stock Market Securities Securities Regulations Financial Reporting Stock Performance Securities Offerings Altimmune, Inc. Disclosure Obligations James Hardie Industries

8 ARTICLES

last mo.

Securities Suit Says Wix Misled Investors on AI Performance and Costs

Multiple national plaintiff firms are soliciting lead plaintiffs before a September 22 deadline to say disclosures about the Base44 acquisition and Wix Harmony triggered steep share losses.

3 ARTICLES

last mo.

Securities Suit Filed Against Grail After NHS‑Galleri Readout Misses Primary Endpoint

7 ARTICLES

4mo ago

Multiple Firms Seek Lead Role in Gossamer Bio Securities Suit After PROSERA Miss

4 ARTICLES

4mo ago

Medpace Investors Urged to Seek Lead Role in Securities Suit Before June 8 Deadline

3 ARTICLES

5mo ago

Rosen Law Reminds Stellantis Investors of June 8 Deadline to Seek Lead Role in Securities Suit

4 ARTICLES

5mo ago

Corcept Investors Face Today’s Lead‑Plaintiff Deadline in Securities Case Over Relacorilant Disclosures

5 ARTICLES

5mo ago

Grocery Outlet Investors Urged to Seek Lead-Plaintiff Role by May 15 in Securities Suits

6 ARTICLES

5mo ago

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Suit Over Relacorilant

3 ARTICLES

5mo ago

Mereo Investors Face Lead‑Plaintiff Deadline in Securities Suit Over Setrusumab Trials

3 ARTICLES

6mo ago

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

8 ARTICLES

6mo ago

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

8 ARTICLES

6mo ago

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

7 ARTICLES

6mo ago

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

5 ARTICLES

6mo ago

NuScale Sued in Securities Class Action Over ENTRA1 Claims and $495 Million Charge

3 ARTICLES

7mo ago

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

Public Companies

Securities Suit Says Wix Misled Investors on AI Performance and Costs

Wise Group Faces Securities Suit Over Alleged AML Failures

Law Firms Urge Investors to Seek Lead Role in Planet Fitness Securities Suit

GrubMarket Confidentially Files for U.S. IPO

Lime Moves Forward With $181 Million IPO Backed by Uber Interest

Investors Mobilize in Commvault Securities Suit Over Alleged ARR Misstatements

Securities Suit Filed Against Grail After NHS‑Galleri Readout Misses Primary Endpoint

Multiple Firms Seek Lead Role in Gossamer Bio Securities Suit After PROSERA Miss

Medpace Investors Urged to Seek Lead Role in Securities Suit Before June 8 Deadline

Rosen Law Reminds Stellantis Investors of June 8 Deadline to Seek Lead Role in Securities Suit

Never miss stories about

Public Companies

Corcept Investors Face Today’s Lead‑Plaintiff Deadline in Securities Case Over Relacorilant Disclosures

Grocery Outlet Investors Urged to Seek Lead-Plaintiff Role by May 15 in Securities Suits

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Suit Over Relacorilant

Mereo Investors Face Lead‑Plaintiff Deadline in Securities Suit Over Setrusumab Trials

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

NuScale Sued in Securities Class Action Over ENTRA1 Claims and $495 Million Charge

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

Never miss stories about

Public Companies